Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Cleveland Clinic, a leading academic medical center, has taken an equity stake in FTA Therapeutics, a Pennsylvania-based developer of antimicrobials, in return for conducting clinical studies with FTA. The studies will be part of a project between FTA and biotech firm Pure Bioscience focused on a silver dihydrogen citrate (SDC) antimicrobial. FTA is completing preclinical work on SDC formulations to prepare for trials on wound care and acne later this year.
This article has been sent to the following recipient: